Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis

Clinical Immunology

Volumn 145, Issue 3, 2012, Pages 230-240

  Shi, Fengmin ^a,b   Guo, Xiaoqin ^a   Jiang, Xingwei ^a   Zhou, Ping ^b   Xiao, Yan ^c   Zhou, Tingting ^a   Chen, Guojiang ^a   Zhao, Zhi ^a   Xiao, He ^a   Hou, Chunmei ^a   Li, Xinying ^a   Yang, Xiaomei ^a   Wang, Renxi ^a   Feng, Jiannan ^a   Shen, Beifen ^a   Li, Yan ^a   Han, Gencheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Gal 9; Immune regulation; T help cells; Tim 3; Ulcerative colitis

Indexed keywords

ANTIBODY; CXCL9 CHEMOKINE; DEXTRAN SULFATE; ECALECTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN; LIGAND; MUCIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFECT; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CELL LINE; CHEMOKINE CXCL10; CHEMOKINE CXCL9; COLITIS, ULCERATIVE; DISEASE MODELS, ANIMAL; GALECTINS; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; LIGANDS; MALE; MEMBRANE PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; RECEPTORS, VIRUS; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84867900850     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.09.001     Document Type: Article

References (43)

1. Kuchroo V.K., Dardalhon V., Xiao S., Anderson A.C. New roles for TIM family members in immune regulation. Nat. Rev. Immunol. 2008, 8:577-580.
2. Nakae S., Iwakura Y., Suto H., et al. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 2007, 81:1258-1268.
3. Seki M., Oomizu S., Sakata K.M., et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
4. Sanchez-Fueyo A., Tian J., Picarella D., et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003, 4:1093-1101.
5. Koguchi K., Anderson D.E., Yang L., O'Connor K.C., Kuchroo V.K., Hafler D.A. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 2006, 203:1413-1418.
6. Liberal R., Grant C.R., Holder B.S., Ma Y., Mieli-Vergani G., Vergani D., Longhi M.S. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology 2012 Aug, 56(2):677-686.
7. + T cells in rheumatoid arthritis. Inflammation 2012, 35:633-637.
8. + T cells evade Treg cell suppression. Nat. Med. Jul 17 2011, 17(8):989-995.
9. Li H., Wu K., Tao K., Chen L., Zheng Q., Lu X., Liu J., Shi L., Liu C., Wang G., Zou W. Tim-3/galectin-9 signaling pathway mediates T cell dysfunction and predicts poor prognosis in patients with HBV-associated hepatocellular carcinoma. Hepatology Apr 13 2012, 10.1002/hep.25777.
10. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
11. Macdonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
12. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
13. Abraham C., Cho J.H. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361:2066-2078.
14. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996, 157:1261-1270.
15. Monteleone G., Biancone L., Marasco R., et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997, 112:1169-1178.
16. Parrello T., Monteleone G., Cucchiara S., et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J. Immunol. 2000, 165:7234-7239.
17. Neurath M.F., Weigmann B., Finotto S., et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 2002, 195:1129-1143.
18. Abraham C., Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15:1090-1100.
19. Liu Z.J., Yadav P.K., Su J.L., Wang J.S., Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2009, 15:5784-5788.
20. Monteleone I., Pallone F., Monteleone G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med. 2011, 15:122.
21. Raza A., Yousaf W., Giannella R., Shata M.T. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev. Clin. Immunol. 2012, 8:161-168.
22. Wirtz S., Neufert C., Weigmann B., et al. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007, 2:541-546.
23. Kim J.J., Shajib M.S., Manocha M.M., Khan W.I. Investigating intestinal inflammation in DSS-induced model of IBD. J. Vis. Exp. 2012, 1. pii: 3678. 10.3791/3678.
24. Li Y.R., Feng J.N., Geng S.X., Han G.C., et al. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity. Mol. Immunol. 2011, 48:670-677.
25. He Wentao, Fang Zemin, Wang Feng, et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009, 88:782-790.
26. Lytle C., Tod T.J., Vo K.T., Lee J.W., Atkinson R.W., Straus D.S. The peroxisome proliferator-activated receptor γ ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm. Bowel Dis. 2005, 11:231-243.
27. Nagalingam N.A., Kao J.Y., Young V.B. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm. Bowel Dis. 2011, 17(4):917-926.
28. Bettelli E., Oukka M., Kuchroo V.K. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
29. Liu L.Y., Bates M.E., Jarjour N.N., Busse W.W., Bertics P.J., Kelly E.A. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J. Immunol. 2007, 179(7):4840-4848.
30. Mikhak Z., Fleming C.M., Medoff B.D., Thomas S.Y., Tager A.M., Campanella G.S., Luster A.D. STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells. J. Immunol. 2006, 176(8):4959-4967.
31. Balasubramani A., Mukasa R., Hatton R.D., et al. Regulation of the Ifng locus in the context of T-lineage specification and plasticity. Immunol. Rev. 2010, 238(1):216-232.
32. +T cell populations. Annu. Rev. Immunol. 2010, 28:445-489.
33. Brown J.B., Cheresh P., Goretsky T., Managlia E., Grimm G.R., Ryu H., Zadeh M., Dirisina R., Barrett T.A. Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection. Infect. Immun. 2011, 79(5):1863-1872.
34. Freeman G.J., Casasnovas J.M., Umetsu D.T., DeKruyff R.H. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 2010, 235:172-189.
35. Li X., Chen G.J., Li Y.R., Han G.C., et al. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin. Immunol. 2010, 134:169-177.
36. Li Y., Anderson D.E., Kuchroo J., Hafler D.A. Lack of TIM-3 immunoregulation in multiple sclerosis. J. Immunol. 2008, 180:4409-4414.
37. Anderson A.C., Anderson D.E. TIM-3 in autoimmunity. Curr. Opin. Immunol. 2006, 18:665-669.
38. Reber S.O., Obermeier F., Straub R.H., Falk W., Neumann I.D. Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice increases the severity of an acute DSS-induced colitis and impairs regeneration. Endocrinology 2006, 147(10):4968-4976.
39. Kovvali Gopala, Das Kiron M. Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Lett. 2005, 579:2261-2266.
40. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., Mankertz J., Gitter A.H., Burgel N., Fromm M., Zeitz M., Fuss I., Strober W., Schulzke J.D. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005, 129:550-564.
41. Aranami T., Yamamura T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 2008, 57:115-120.
42. Shahrara S., Huang Q., Mandelin A.M., Pope R.M. TH-17 cells in rheumatoid arthritis. Arthritis Res. Ther. 2008, 10:R93.
43. Zhao Y., Yang J., Gao Y.D., Guo W. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 2010, 151:297-307.